06/10/2026
Millions of people have benefited from Ozempic®, Wegovy®, and other GLP-1 medications—but emerging research is highlighting an important eye health consideration.
In June 2025, the World Health Organization issued a safety alert regarding a possible link between semaglutide medications and a rare optic nerve condition called NAION.
The risk remains low, but sudden vision changes should never be ignored.
Our latest blog explains:
✔ What NAION is
✔ Symptoms to watch for
✔ Who may be at higher risk
✔ Why routine eye exams matter
Whether you're working long shifts in healthcare, commuting along I-35, or focused on improving your overall wellness, protecting your vision should remain part of the plan.
Read the full blog here
Visit VIEW Temple in Temple to learn how Ozempic and other GLP-1 medications may affect vision, and the signs of NAION.